Home Other Building Blocks 6377-18-0
6377-18-0,MFCD00467138
Catalog No.:AA00E9LB

6377-18-0 | CHARTREUSIN

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥98%
in stock  
$70.00   $49.00
- +
5mg
≥98%
in stock  
$205.00   $143.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00E9LB
Chemical Name:
CHARTREUSIN
CAS Number:
6377-18-0
Molecular Formula:
C32H32O14
Molecular Weight:
640.5881
MDL Number:
MFCD00467138
SMILES:
COC1C(O)C(OC2C(OC(C(C2O)O)C)Oc2cccc3c2c2oc(=O)c4c5c2c(c3O)c(=O)oc5ccc4C)OC(C1O)C
Properties
Computed Properties
 
Complexity:
1150  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
10  
Heavy Atom Count:
46  
Hydrogen Bond Acceptor Count:
14  
Hydrogen Bond Donor Count:
5  
Rotatable Bond Count:
5  
XLogP3:
2.1  

Literature

Title: Identification of hepatitis C virus inhibitors targeting different aspects of infection using a cell-based assay.

Journal: Antimicrobial agents and chemotherapy 20121201

Title: Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.

Journal: Bioorganic & medicinal chemistry 20121115

Title: A new origin for chartreusin.

Journal: Chemistry & biology 20050501

Title: Biosynthesis of the antitumor agent chartreusin involves the oxidative rearrangement of an anthracyclic polyketide.

Journal: Chemistry & biology 20050501

Title: Elsamicin A binding to DNA. A comparative thermodynamic characterization.

Journal: FEBS letters 20041008

Title: Chartreusin, elsamicin A and related anti-cancer antibiotics.

Journal: Current medicinal chemistry. Anti-cancer agents 20031101

Title: Crystal structure of chartreusin derivative A132.

Journal: Carbohydrate research 20030704

Title: Pharmacokinetic and pharmacodynamic study of IST-622, a novel synthetic derivative of chartreusin, by oral administration in a phase II study of patients with breast cancer.

Journal: Cancer chemotherapy and pharmacology 20020601

Title: DNA-unwinding test using eukaryotic DNA topoisomerase I.

Journal: Methods in molecular biology (Clifton, N.J.) 20010101

Title: Determination of Elsamitrucin (BMY-28090) in plasma and urine by high-performance liquid chromatography with fluorescence detection.

Journal: Journal of chromatography 19931222

Title: Screening for new compounds with antiherpes activity.

Journal: Antiviral research 19841001

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:6377-18-0 Molecular Formula|6377-18-0 MDL|6377-18-0 SMILES|6377-18-0 CHARTREUSIN